Tillman Gerngross and Ram Sasisekharan
March 20, 2023 11:12 AM EDT
People

'No find­ing of re­search mis­con­duc­t': MIT ends 3.5-year re­view of biotech founder, pro­fes­sor Sasisekha­ran

Kyle LaHucik

Senior Reporter

The Mass­a­chu­setts In­sti­tute of Tech­nol­o­gy said it found no re­search mis­con­duct af­ter al­le­ga­tions were levied against bi­o­log­i­cal en­gi­neer­ing pro­fes­sor and re­peat biotech founder Ram Sasisekha­ran …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times